Usual Adult Dose for Postoperative Ocular Inflammation

0.07% and 0.09% Ophthalmic Solutions: 1 drop in the affected eye(s) once a day beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 14 days of the postoperative period

0.075% Ophthalmic Solution: 1 drop in the affected eye(s) twice a day (morning and evening) beginning 1 day prior to surgery, continued on the day of surgery, and for 14 days postsurgery

Comments:

• This drug may be administered in conjunction with other topical ophthalmic drugs such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.
• If more than one topical ophthalmic drug is being used, each one should be administered at least 5 minutes apart.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Storage requirements:

• Do not store above 25 C (77F)

• To prevent contamination of the dropper-tip and solution, care should be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper-tip of the bottle; wash hands prior to use.
• Do not wear contact lenses during administration of this drug; may be reinserted 10 minutes after application.
• If concomitant topical ophthalmic medication is being used, administer at least 5 minutes apart.